The AHA and Federation of American Hospitals today urged the U.S. Supreme Court to review a federal appeals court decision that allows False Claims Act whistleblowers to accuse a hospital or other defendant of fraud and proceed to discovery without articulating specific facts demonstrating the circumstances or scope of the alleged fraud.
 
“The question here is whether private plaintiffs pursuing FCA claims should have to follow the same basic rules of civil litigation that apply to every other plaintiff pursuing a fraud claim, or whether they should be treated as a special class of plaintiff entitled to a court-made exception from those rules,” the associations said in a friend-of-the-court brief filed in the case. “Amici and their members submit that they should not be. … The Tenth Circuit’s relaxed standard strips away the protections [Federal Rule of Civil Procedure 9(b)] affords other defendants. Discovery in FCA cases can be enormously expensive, even when it confirms that the relator could not plead the circumstances of any fraud because no fraud occurred. For all hospitals, the costs are an unnecessary diversion of resources from patient care; for community hospitals in particular, these consequences can be devastating. This Court should grant certiorari to restore the consistent application of the plain text of Rule 9(b) in all fraud cases, including those brought under the FCA.”
 

Related News Articles

Headline
The House Appropriations Committee July 10 voted 31-25 to approve legislation that would provide $185.8 billion in funding for the departments of Labor, Health…
Headline
The House Energy and Commerce Committee June 12 passed AHA-supported legislation during a markup of bills that passed the Health Subcommittee in May. The…
Headline
The AHA praised House and Senate leaders in letters June 12 for reintroducing the Improving Seniors’ Timely Access to Care Act, bipartisan legislation that…
Headline
The AHA June 7 submitted comments on a discussion draft of the Drug Shortage Prevention and Mitigation Act, bipartisan legislation proposing to provide…
Headline
The House Energy and Commerce Oversight and Investigations subcommittee June 4 hosted a hearing to discuss oversight of the 340B Drug Pricing Program. AHA sent…
Headline
A coalition of 230 national associations, including the AHA, submitted a letter the week of May 20 to the Federal Trade Commission requesting a stay on the…